June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.46 billion in 2025, with a CAGR of 6.96%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global cementless total knee arthroplasty market size is predicted to surpass around USD 28.29 billion by 2035 from USD 4.58 billion in 2025, with a solid CAGR of 19.97%.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
May 2026
The global aesthetic injectables market size is estimated to hit around USD 43.98 billion by 2035 increasing from USD 13.81 billion in 2025, with a CAGR of 12.28%.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
March 2026
The global non-injectable insulin market size is expected to increase from USD 1.88 billion in 2025 and is expected to hit around USD 5.63 billion by 2034 at a CAGR of 12.99%.
March 2026
The global generic injectable market size is expected to increase from USD 133.34 billion in 2025 and is expected to reach around USD 482.50 billion by 2035 with a CAGR of 13.72%.
March 2026
The global knee replacement market size is expected to increase from USD 11.06 billion in 2025 and is expected to hit around US 18.15 billion by 2035, with a CAGR of 5.08%.
March 2026
The global facial injectable market size is expected to increase from USD 14.41 billion in 2025 to hit around USD 44.05 billion by 2035, with a CAGR of 11.82%.
February 2026
The generic sterile injectable market size is estimated to hit around USD 124.44 billion by 2035 increasing from USD 51.17 billion in 2025, with a CAGR of 9.29%.
January 2026
The injectable drug delivery market size was valued at USD 764.6 billion in 2025 and is projected to hit around USD 1,719.57 billion by 2035 with a CAGR of 8.45%.
December 2025
The osteoarthritis therapeutics market size accounted for USD 10.84 billion in 2025 and is expected to hit around USD 26.31 billion by 2035 with a CAGR of 9.27%.
August 2025
The global long-acting injectables (LAIs) market size was evaluated at USD 16.94 billion in 2024 and is predicted to hit around USD 57.26 billion by 2034, growing at a CAGR of 12.95%.
August 2025
The global medical aesthetic treatments market growth is fueled by advancements in laser technology, injectables, and rising patient preference for aesthetic care.
August 2025
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 19.48 billion in 2024, with a CAGR of 6.25%.
July 2025
Next-gen dermatology treatments market booming with AI diagnostics, microneedles, biologics & telehealth innovation.
July 2025
The lyophilized injectable drugs market size was valued at USD 353.67 billion in 2024 and is expected to attain around USD 1,330.78 billion by 2034, with a CAGR of 8.84%.
July 2025
Discover how the next gen cardiovascular treatments market is revolutionizing cardiac care through smart devices, gene therapy, and AI.
June 2026
The global orthodontics market size was valued at USD 23.81 billion in 2025 and is expected to reach over USD 70.6 billion by 2035, growing at a CAGR of 11.49%.
February 2026
The global non-invasive aesthetic treatment market is evaluated at USD 22.67 billion in 2025 and is predicted to hit around USD 43.75 billion by 2035, at a CAGR of 6.8%.
August 2025
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
August 2025
The global human chorionic gonadotropin market size is projected to surge around USD 2.94 billion by 2034 from USD 2.15 billion in 2024, with a CAGR of 3.20%.
August 2025
The global epidermal growth factors (EGFs) market size is estimated to hit around USD 1.72 billion by 2034 increasing from USD 1.19 billion in 2024, with a CAGR of 3.75%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
August 2025
The global platelet-derived growth factors market size is estimated to hit around USD 3.23 billion by 2034 increasing from USD 1.3 billion in 2024, with a CAGR of 9.54%.
July 2025
The home dialysis systems market size was evaluated at USD 23.55 billion in 2024 and is predicted to surge around USD 32.24 billion by 2034, with a CAGR of 10.21%.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
June 2025
The influenza drug market size was evaluated at USD 1.09 billion in 2024 and is expected to surge around USD 1.38 billion by 2034 with a CAGR of 2.39%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com